Angelini Pharma Drug Patent Portfolio
Angelini Pharma owns 1 orange book drug protected by 3 US patents Given below is the list of Angelini Pharma's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8133893 | Trazodone and trazodone hydrochloride in purified form | 13 Mar, 2029 | Active |
| US7829120 | Trazodone composition for once a day administration | 27 Mar, 2027 | Active |
| US6607748 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture | 29 Jun, 2020 | Expired |
Latest Legal Activities on Angelini Pharma's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Angelini Pharma.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 12th Year, Large Entity | 06 Sep, 2023 | US8133893 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 03 May, 2022 | US7829120 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 05 Sep, 2019 | US8133893 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 30 Apr, 2018 | US7829120 |
| Post Issue Communication - Certificate of Correction | 13 Aug, 2012 | US8133893 |
|
Recordation of Patent Grant Mailed
Critical
| 13 Mar, 2012 | US8133893 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 13 Mar, 2012 | US8133893 |
|
Email Notification
Critical
| 23 Feb, 2012 | US8133893 |
|
Issue Notification Mailed
Critical
| 22 Feb, 2012 | US8133893 |
| Dispatch to FDC | 09 Feb, 2012 | US8133893 |
| Printer Rush- No mailing | 01 Feb, 2012 | US8133893 |
|
Pubs Case Remand to TC
Critical
| 31 Jan, 2012 | US8133893 |
|
Application Is Considered Ready for Issue
Critical
| 25 Jan, 2012 | US8133893 |
|
Issue Fee Payment Verified
Critical
| 24 Jan, 2012 | US8133893 |
|
Issue Fee Payment Received
Critical
| 24 Jan, 2012 | US8133893 |
Angelini Pharma's Family Patents
Angelini Pharma drugs have patent protection in a total of 30 countries. It's US patent count contributes only to 30.0% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Angelini Pharma Drug List
Given below is the complete list of Angelini Pharma's drugs and the patents protecting them.
1. Oleptro
Oleptro is protected by 3 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8133893 | Trazodone and trazodone hydrochloride in purified form |
13 Mar, 2029
(4 years from now)
| Active |
| US7829120 | Trazodone composition for once a day administration |
27 Mar, 2027
(2 years from now)
| Active |
| US6607748 | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
29 Jun, 2020
(4 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Oleptro's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List